LifeMD Reports Q2 2026 Financial Results

What Happened
LifeMD, Inc. announced its financial results for the three and six months ended June 30, 2026 by issuing a press release on August 5, 2026 (furnished as Exhibit 99.1 to the Form 8-K). The company also furnished an investor presentation (Exhibit 99.2) that it expects to use, in whole or in part and possibly with modifications, in presentations to investors and analysts beginning August 5, 2026; the presentation is also posted on LifeMD’s website. The filing includes standard Regulation FD and forward-looking statements disclaimers.

Key Details

• Press release announcing Q2 2026 results issued August 5, 2026 and furnished as Exhibit 99.1.
• Results cover the three- and six-month periods ended June 30, 2026.
• Investor presentation furnished as Exhibit 99.2 and available at https://lifemd.com; may be used in investor/analyst presentations.
• Filing contains forward-looking statement cautions and states the Company is not obligated to update statements except as required by law.

Why It Matters
This 8-K signals that LifeMD has released its quarterly financial results and provided an updated investor presentation — both sources that investors should review for details on earnings, revenue, cash flow and management commentary. The Form 8-K itself mainly notes the release and furnishes materials; it does not include the full financial detail in-line, so investors should read the attached press release and presentation (or other SEC filings) for the specific numbers and risk disclosures.